Regulation of rat and human T-cell immune response by pharmacologically modified dendritic cells

Transplantation

Volumn 87, Issue 11, 2009, Pages 1617-1628

  Fazekasova, Henrieta ^a   Golshayan, Dela ^b   Read, Joseph ^c   Tsallios, Aristotle ^c   Tsang, Julia Yuen Shan ^a   Dorling, Anthony ^c   George, Andrew J T ^c   Lechler, Robert I ^a   Lombardi, Giovanna ^a   Mirenda, Vincenzo ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Dendritic cells; Regulation; T cells

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CYTOKINE; DEXAMETHASONE; INTERLEUKIN 10; INTERLEUKIN 2;

ANIMAL CELL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLONAL ANERGY; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIGENS, CD4; BONE MARROW CELLS; CYTOKINES; DENDRITIC CELLS; DEXAMETHASONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNE SYSTEM PROCESSES; IMMUNE TOLERANCE; LYMPH NODES; LYMPHOCYTE CULTURE TEST, MIXED; RATS; RATS, INBRED BN; RATS, INBRED LEW; SPLEEN; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 67649604470     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181a5504c     Document Type: Article

References (38)

1. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767.
2. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21: 685.
3. Yamazaki S, Iyoda T, Tarbell K, et al. Direct expansion of functional CD25- CD4- regulatory T cells by antigen-processing dendritic cells. J Exp Med 2003; 198: 235.
4. Hackstein H, Thomson AW. Dendritic cells: Emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 2004; 4: 24.
5. Hackstein H, Morelli AE, Thomson AW. Designer dendritic cells for tolerance induction: Guided not misguided missiles. Trends Immunol2001; 22: 437.
6. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007; 7: 610.
7. Moser M, De Smedt T, Sornasse T, et al. Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. Eur J Immunol 1995; 25: 2818.
8. Rea D, Van Kooten C, van Meijgaarden KE, et al. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. Blood 2000; 95: 3162.
9. Woltman AM, van der Kooij SW, de Fijter JW, et al. Maturation-resistant dendritic cells induce hyporesponsiveness in alloreactive CD45RA-and CD45RO-T-cell populations. Am J Transplant 2006; 6: 2580.
10. Matyszak MK, Citterio S, Rescigno M, et al. Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur J Immunol 2000; 30: 1233.
11. Adorini L, Penna G, Giarratana N, et al. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J Cell Biochem2003; 88: 227.
12. Buckland M, Jago C, Fazekesova H, et al. Aspirin modified dendritic cells are potent inducers of allo-specific regulatory T-cells. Int Immunopharmacol2006; 6: 1895.
13. Mirenda V, Berton I, Read J, et al. Modified dendritic cells coexpressing self and allogeneic major histocompatability complex molecules: An efficient way to induce indirect pathway regulation. J Am Soc Nephrol2004; 15: 987.
14. Talmor M, Mirza A, Turley S, et al. Generation of large number of immature and mature dendritic cells from rat bone marrow cultures. Eur J Immunol 1998; 28: 811.
15. Zhou LJ, Tedder TF. CD14-blood monocytes can differentiate into functionally mature CD83-dendritic cells. Proc Natl Acad Sci USA1996; 93: 2588.
16. King WJ, Comer RM, Hudde T, et al. Cytokine and chemokine expression kinetics after corneal transplantation. Transplantation 2000; 70: 1225.
17. Golshayan D, Jiang S, Tsang J, et al. In vitro-expanded donor alloantigenspecific CD4-CD25- regulatory T cells promote experimental transplantation tolerance. Blood 2007; 109: 827.
18. Scott K, Manunta M, Germain C, et al. Qualitatively distinct patterns of cytokines are released by human dendritic cells in response to different pathogens. Immunology 2005; 116: 245.
19. Mitchell P, Germain C, Fiori PL, et al. Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development. Infect Immun 2007; 75: 810.
20. Abe M, Thomson AW. Dexamethasone preferentially suppresses plasmacytoid dendritic cell differentiation and enhances their apoptotic death. Clin Immunol 2006; 118: 300.
21. DeSilva DR, Urdahl KB, Jenkins MK. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J Immunol1991; 147: 3261.
22. Garrovillo M, Ali A, Oluwole SF. Indirect allorecognition in acquired thymic tolerance: Induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells. Transplantation1999; 68: 1827.
23. Oluwole OO, Depaz HA, Gopinathan R, et al. Indirect allorecognition in acquired thymic tolerance: Induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells. Diabetes 2001; 50: 1546.
24. Legge KL, Gregg RK, Maldonado-Lopez R, et al. On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity. J Exp Med 2002; 196: 217.
25. Akbari O, Freeman GJ, Meyer EH, et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergeninduced airway hyperreactivity. Nat Med 2002; 8: 1024.
26. Murakami M, Sakamoto A, Bender JR, et al. CD25-CD4- T cells contribute to the control of memory CD8-T cells. Proc Natl Acad Sci USA2002; 99: 8832.
27. Canning MO, Grotenhuis K, de Wit HJ, et al. Opposing effects of dehydroepiandrosterone and dexamethasone on the generation of monocyte-derived dendritic cells. Eur J Endocrinol 2000; 143: 687.
28. Woltman AM, de Fijter JW, Kamerling SW, et al. The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur J Immunol 2000; 30: 1807.
29. Vanderheyde N, Verhasselt V, Goldman M, et al. Inhibition of human dendritic cell functions by methylprednisolone. Transplantation 1999; 67: 1342.
30. de Jong EC, Vieira PL, Kalinski P, et al. Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3. J Leukoc Biol 1999; 66: 201.
31. Piemonti L, Monti P, Allavena P, et al. Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol 1999; 162: 6473.
32. Duperrier K, Velten FW, Bohlender J, et al. Immunosuppressive agents mediate reduced allostimulatory properties of myeloid-derived dendritic cells despite induction of divergent molecular phenotypes. Mol Immunol 2005; 42: 1531.
33. Coates PT, Thomson AW. Dendritic cells, tolerance induction and transplant outcome. Am J Transplant 2002; 2: 299.
34. Lechler R, Chai JG, Marelli-Berg FM, et al. The contributions of T-cell anergy to peripheral T-cell tolerance. Immunology 2001; 103: 262.
35. Moreau A, Chiffoleau E, Beriou G, et al. Superiority of bone marrowderived dendritic cells over monocyte-derived ones for the expansion of regulatory T cells in the macaque. Transplantation 2008; 85: 1351.
36. Xia CQ, Peng R, Beato F, et al. Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scand J Immunol2005; 62: 45.
37. Roelen DL, van den Boogaardt DE, van Miert PP, et al. Differentially modulated dendritic cells induce regulatory T cells with different characteristics. Transpl Immunol 2008; 19: 220.
38. Battaglia M, Stabilini A, Draghici E, et al. Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes 2006; 55: 40.